🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The pathophysiology of the most common corneal endothelial dystrophies (Fuc...
Status
Recruiting
Location
CHU Saint-Etienne
Start Date
2024-08-08
Trial ID
NCT05742321
Treatments Being Tested
A study to assess the safety and efficacy of K-321 in participants with FEC...
Status
Completed
Location
Keck Hospital of USC
Start Date
2023-05-11
Trial ID
NCT05826353
A study to assess the safety and efficacy of K-321 in participants with FEC...
Status
Completed
Location
Keck Hospital of USC
Start Date
2023-03-30
Trial ID
NCT05795699
A pilot study designed to assess the feasibility of planned descemetorhexis...
Status
Completed
Location
The Medical College of Wisconsin
Start Date
2014-01
Trial ID
NCT02206594
Treatments Being Tested
This will be a prospective assessment of whether adjuvant Netarsudil use in...
Status
Completed
Location
Massachusetts Eye and Ear Infirmary
Start Date
2021-03-28
Trial ID
NCT04752020
Treatments Being Tested
The cornea forms our "window to the world". Hence, its transparency is of u...
Status
Unknown
Location
Department of Ophthalmology, University of Erlangen-Nürnberg
Start Date
2018-06-05
Trial ID
NCT03575130
Treatments Being Tested
Primary aim of the study is to determine whether a rho kinase inhibitor, Ne...
Status
Completed
Location
Massachusetts Eye and Ear Infirmary
Start Date
2018-10-02
Trial ID
NCT04057053
Treatments Being Tested
The objective of this study is to investigate the effect of K-321 in patien...
Status
Completed
Location
Jules Stein Eye Institute
Start Date
2020-06-23
Trial ID
NCT04250207
Treatments Being Tested